Supplementary Figure S4 from Early Clearance of Plasma &lt;i&gt;Epidermal Growth Factor Receptor&lt;/i&gt; Mutations as a Predictor of Outcome on Osimertinib in Advanced Non–Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURA